CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net income	$ 264,222	$ 352,712	$ 2,394,489
Adjustments to reconcile net income to cash provided by (used in) operating activities:
Depreciation and amortization	189,331	184,148	197,111
Stock based compensation	34,067	0	0
(Gain) loss on marketable securities, net	(12,233)	(10,941)	14,340
Gain on CLS Sale	0	0	(2,283,820)
Gain on sale leaseback of German warehouse	0	0	(7,050)
Noncash charges for interest and bond discount amortization	26,374	31,424	33,419
Loss on repayment of term loans	1,927	4,872	10,724
Amortization of operating lease asset	128,935	108,644	101,263
Deferred income taxes	(14,984)	(55,164)	16,573
(Gain) loss on foreign exchange	(130)	1,989	(143,335)
Other	(1,164)	4,805	6,973
Changes in operating assets and liabilities, net of effects of acquisitions:
Trade accounts receivable	(1,060,810)	(299,833)	(590,576)
Inventory	(225,831)	772,396	(210,215)
Other assets	(18,917)	(75,597)	(30,322)
Accounts payable	976,171	(738,389)	349,744
Change in book overdrafts	134,652	(34,367)	10,411
Operating lease liabilities	(118,975)	(104,897)	(63,799)
Accrued expenses and other	31,204	(82,978)	(167,039)
Cash provided by (used in) operating activities	333,839	58,824	(361,109)
Cash flows from investing activities:
Capital expenditures	(142,703)	(201,535)	(135,785)
Proceeds from deferred purchase price of factored receivables	252,199	162,622	145,003
Issuance of notes receivable	(57,117)	0	0
Proceeds from note receivables	38,291	0	0
Proceeds from CLS sale, net of cash sold	0	23,977	2,977,825
Proceeds from sale leaseback of German warehouse	0	0	43,691
Other	14,871	(2,778)	(1,966)
Cash provided by (used in) investing activities	105,541	(17,714)	3,028,768
Cash flows from financing activities:
Payment of contingent consideration related to Imola Mergers	0	0	(250,000)
Dividends paid to shareholders	(6,174)	(10,462)	(1,753,697)
Change in unremitted cash collections from servicing factored receivables	(11,315)	(18,413)	17,831
Proceeds from issuance of common stock in initial public offering, net of underwriting discounts	241,164	0	0
Repayment of term loans	(483,100)	(560,000)	(517,500)
Gross proceeds from other debt	101,779	72,351	50,116
Gross repayments of other debt	(118,331)	(92,417)	(94,300)
Net (repayments of) proceeds from revolving and other credit facilities	(66,998)	131,467	89,285
Repurchase of common stock for tax withholdings on equity awards	(14,164)	0	0
Purchase of Colsof shares	(22,621)	0	0
Other	(11,539)	(466)	(7,048)
Cash used in financing activities	(391,299)	(477,940)	(2,465,313)
Effect of exchange rate changes on cash and cash equivalents	(78,170)	65,183	(133,817)
Cash and cash equivalents classified within held for sale	0	0	23,729
(Decrease) increase in cash and cash equivalents	(30,089)	(371,647)	92,258
Cash and cash equivalents, beginning of year	948,490	1,320,137	1,227,879
Cash and cash equivalents, end of year	918,401	948,490	1,320,137
Supplemental disclosures of cash flow information:
Interest	336,431	378,554	320,025
Income taxes	252,219	271,541	442,564
Supplemental disclosure of non-cash investing and financing information:
Proceeds not yet received from CLS sale	0	0	23,997
Amounts obtained as a beneficial interest in exchange for transferring trade receivables in factoring arrangements	$ 261,667	$ 171,114	$ 147,882